These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 10133357)

  • 41. Commentary: pharmacoeconomics and outcomes research: expanding the healthcare "outcomes" market.
    Hay JW; Yu WM
    Value Health; 2000; 3(3):181-5. PubMed ID: 16464182
    [No Abstract]   [Full Text] [Related]  

  • 42. Look beyond financial conflicts of interest in evaluating industry-academia collaborations in burden-of-illness and outcomes research studies in dermatology.
    Prendergast MM; Abramovits W; Boguniewicz M; Lebwohl M; Tokar M; Tong KB
    J Invest Dermatol; 2004 Sep; 123(3):452-4. PubMed ID: 15304081
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Industry funded clinical trials: bias and quality.
    Del Parigi A
    Curr Med Res Opin; 2012 Jan; 28(1):23-5. PubMed ID: 22103762
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Industry funding and author-industry affiliation in clinical trials in psychiatry.
    Montgomery JH
    Am J Psychiatry; 2006 Jun; 163(6):1110-1; author reply 1111. PubMed ID: 16741218
    [No Abstract]   [Full Text] [Related]  

  • 45. Industry sponsored bias in cost effectiveness analyses.
    John-Baptiste A; Bell C
    BMJ; 2010 Oct; 341():c5350. PubMed ID: 20943724
    [No Abstract]   [Full Text] [Related]  

  • 46. The potential for bias in reporting of industry-sponsored clinical trials.
    Pyke S; Julious SA; Day S; O'Kelly M; Todd S; Matcham J; Seldrup J
    Pharm Stat; 2011; 10(1):74-9. PubMed ID: 21275037
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmaceutical company-sponsored drug trials: what are we to believe?
    Shekelle P
    J Clin Epidemiol; 2010 Feb; 63(2):126-7. PubMed ID: 19836207
    [No Abstract]   [Full Text] [Related]  

  • 48. Company sponsored clinical research--it can be trusted.
    Arnold J; Hofmann L; Rupinskas VR
    Decubitus; 1989 Feb; 2(1):22-4. PubMed ID: 2751831
    [TBL] [Abstract][Full Text] [Related]  

  • 49. How to keep your integrity when performing sponsored (imaging) trials.
    Parizel PM; van Hecke W
    J Am Coll Radiol; 2011 Dec; 8(12):842-7. PubMed ID: 22137001
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The relationship between study sponsorship, risks of bias, and research outcomes in atrazine exposure studies conducted in non-human animals: Systematic review and meta-analysis.
    Bero L; Anglemyer A; Vesterinen H; Krauth D
    Environ Int; 2016; 92-93():597-604. PubMed ID: 26694022
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Conflict of interest. Part 2.
    Grey JE
    Healthc Forum J; 1990; 33(6):96-9. PubMed ID: 10108264
    [No Abstract]   [Full Text] [Related]  

  • 52. Influence of drug company authorship and sponsorship on drug trial outcomes.
    Tungaraza T; Poole R
    Br J Psychiatry; 2007 Jul; 191():82-3. PubMed ID: 17602130
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Health care professionals and industry: reducing conflicts of interest and established best practices.
    Weber LJ; Wayland MT; Holton B
    Arch Phys Med Rehabil; 2001 Dec; 82(12 Suppl 2):S20-4. PubMed ID: 11805916
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ethical issues in managed care.
    Hofmann PB
    Healthc Exec; 1994; 9(2):40. PubMed ID: 10132276
    [No Abstract]   [Full Text] [Related]  

  • 55. Commentary: But what should journals actually do to keep industry sponsored research unbiased?
    Del Mar C
    BMJ; 2010 Oct; 341():c5406. PubMed ID: 20940215
    [No Abstract]   [Full Text] [Related]  

  • 56. Drug firm conflicting interests. If only industry funded trials were as well done as the WHI.
    Barrington KJ
    BMJ; 2009 Dec; 339():b5655. PubMed ID: 20044404
    [No Abstract]   [Full Text] [Related]  

  • 57. Corporate-sponsored research contracts--an ethical minefield.
    Simonsen RJ
    Quintessence Int; 1996 Jul; 27(7):443. PubMed ID: 8941819
    [No Abstract]   [Full Text] [Related]  

  • 58. Minimizing the influence of drug marketing.
    Hester FG
    Hospitals; 1990 Aug; 64(15):80. PubMed ID: 2373503
    [No Abstract]   [Full Text] [Related]  

  • 59. Registering clinical trials.
    Dickersin K; Rennie D
    JAMA; 2003 Jul; 290(4):516-23. PubMed ID: 12876095
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Issues pertaining to the critiques of the SAINT-I Trial.
    Fisher M; Hess DC; Lees K
    Stroke; 2007 Nov; 38(11):e126-7; author reply e128. PubMed ID: 17968005
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.